The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors.
Systemic application of first-generation adenovirus induces pathogenic effects in the liver. To begin unraveling the mechanisms underlying early liver toxicity after adenovirus infusion, particularly the role of macrophage activation and expression of viral genes in transduced target cells, first-generation adenovirus or adenovirus vectors that lacked most early and late gene expression were administered to C3H/HeJ mice after transient depletion of Kupffer cells by gadolinium chloride treatment. Activation of NF-kappaB, and the serum levels of the proinflammatory cytokines tumor necrosis factor (TNF) and interleukin-6 (IL-6) were studied in correlation with liver damage, apoptosis, and hepatocellular DNA synthesis. While Kupffer cell depletion nearly eliminated adenovirus-induced TNF release, it resulted in a more robust IL-6 release. These responses were greatly reduced in animals receiving the deleted adenovirus. Although there were quantitative differences, NF-kappaB activation was observed within minutes of first-generation or deleted adenovirus vector administration regardless of the status of the Kupffer cells, suggesting that the induction is related to a direct effect of the virus particle on the hepatocyte. Early liver toxicity as determined by serum glutamic-pyruvic transaminase elevation and inflammatory cell infiltrates appeared to be dependent on adenovirus-mediated early gene expression and intact Kupffer cell function. Kupffer cell depletion had little effect on adenovirus-mediated hepatocyte apoptosis but did increase hepatocellular DNA synthesis. Finally, Kupffer cell depletion decreased the persistence of transgene (human alpha1-antitrypsin [hAAT]) expression that was associated with a more pronounced humoral immune response against hAAT. The elucidation of these events occurring after intravenous adenovirus injection will be important in developing new vectors and transfer techniques with reduced toxicity.
Lieber
A
A
Department of Medicine, University of Washington, Seattle 98195, USA.
He
C Y
CY
Meuse
L
L
Schowalter
D
D
Kirillova
I
I
Winther
B
B
Kay
M A
MA
D000256:Adenoviridae / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity*; D000818:Animals; D016207:Cytokines / Q000378:metabolism; D004247:DNA / Q000096:biosynthesis; D005682:Gadolinium / Q000494:pharmacology; D015967:Gene Expression Regulation, Viral; D005822:Genetic Vectors / Q000009:adverse effects; D007728:Kupffer Cells / Q000276:immunology*; D008107:Liver Diseases / Q000276:immunology / Q000821:virology*; D051379:Mice; D008809:Mice, Inbred C3H; D016513:Mice, SCID; D019076:Transgenes / Q000235:genetics
D016207:Cytokines; D004247:DNA; D005682:Gadolinium